HY-0721

N/A

Report date: 2024/12/10 13:17:15
NME

Base Information

Drug NameHY-0721
Drug Alias NameHY0721HY-0721HT-13SPT-07B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSUR1-TRPM4 inhibitors
TargetsSulfonylurea receptor 1Transient receptor potential cation channel subfamily M member 4
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Pharmavan Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSuzhou Pharmavan Co Ltd
Inactive CompaniesN/A
Active IndicationsStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A